Treatments

Most widely used treatment for hemophilia today is called replacement therapy. Hemophiliacs inject a concentration of factor VIII or IX, depending on their deficiency. The factor can be made from human or animal plasma. Though with modern technology the risk of contracting the infectious disease from human blood is small, factor made from animals is safer and is called recombinant. The recombinant factor can be taken on regular basis as preventive measure or it can be taken when a bleeding incident occurs. There are, however, some complications that can occur with this treatment. Hemophiliacs may develop antibodies to the clotting factor. These antibodies attic the recombinant factor preventing it from taking effect. If this occurs, doctors usually prescribe higher dosage of the factor.